Preparation and its release in vitro of multivesicular liposomes containing cytarabine 阿糖胞苷多囊脂质体的制备及体外释放度考察
Clinical study of homoharringtonine and low-dose cytarabine in myeloproliferative diseases 高三尖杉酯碱联合小剂量阿糖胞苷治疗骨髓增殖性疾病疗效观察
Efficacy of aclacinomycin plus intermediate dose of cytarabine for patients with refractory and relapsed acute myeloid leukemia 阿柔比星联合中剂量阿糖胞苷诱导治疗难治和复发性急性髓样白血病的疗效
Low dose of homoharringtonine and cytarabine combined with G-CSF for treatment of acute myelocytic leukemia: report of 28 cases 小剂量高三尖杉酯碱、阿糖胞苷联合G-CSF治疗急性髓细胞白血病28例临床分析
Effect of Azone on Cytarabine for Percutaneous Absorption 氮酮对阿糖胞苷乳膏体外透皮吸收作用的影响
Acute Lymphoblastic Leukemia Treated by Intermediate-Dose Cytarabine in Children 中剂量阿糖胞苷治疗儿童急性淋巴细胞白血病
The Combination of Mitoxantrone and Cytarabine in treatment of 30 patients with Acute Non-lymphocytic Leukemia 米托蒽醌和阿糖胞苷方案治疗急性非淋巴细胞白血病30例
Chemotherapeutic effect of two different doses of cytarabine combined with anthracycline for CD7 positive acute myeloid leukemia 不同剂量阿糖胞苷的DA方案治疗CD7抗原阳性急性髓系白血病疗效分析
Effect of high-dose cytarabine chemotherapy on long-term survival of patients with acute myeloid leukemia 大剂量阿糖胞苷强化疗对急性髓性白血病长期生存的影响
Standard-dose of Idarubicin in Combination with Continuous Infusion of Cytarabine as Induction Therapy in Patients with Acute Myeloid Leukaemia 标准剂量去甲氧柔红霉素联合阿糖胞苷持续静脉点滴治疗急性髓系白血病
Cytarabine enhances B7 expression on leukemic cells and promotes cytotoxic effect of bispecific antibody against target cells 阿糖胞苷增强白血病细胞B7分子表达及促进双功能抗体对靶细胞的杀伤
Determination of cytarabine and uracil arabinoside in plasma by HPLC HPLC法测定血浆中阿糖胞苷及阿糖尿苷浓度
We previously reported the feasibility of clofarabine and cytarabine combinations in AML. 我们此前报道了氯法拉滨与阿糖胞苷联合使用治疗AML的可行性。
HPLC Method for the Determination of Related Substances in Cytarabine Injection 高效液相色谱法测定阿糖胞苷注射液中有关物质的含量
The pretreatment regimen was Cytarabine, Etoposide, Cyclophosphamide and total body irradiation. 预处理选用阿糖胞苷、足叶乙苷、环磷酰胺和全身照射。
Cytarabine in the Treatment of Acute Promyelocytic Leukemia: A Systematic Review 阿糖胞苷治疗急性早幼粒细胞白血病疗效随机对照试验的系统评价
Objective To investigate the expression of deoxycytidine kinase ( DCK) and cytidine deaminase ( CDA) gene in children with acute leukemia and to explore the relationship between gene expression and clinical response to cytarabine ( Ara-C). 目的通过测定急性白血病(AL)患儿脱氧胞苷激酶(DCK)和胞苷脱氨酶(CDA)基因的表达,探讨其与阿糖胞苷(Ara-C)耐药及临床疗效间的关系。
Objective To observe the therapeutic effects of high-dose cytarabine ( HD-Ara-C) in the treatment of patients with remission of acute myeloid leukemia ( AML). 目的观察急性髓性白血病(AML)缓解后应用大剂量阿糖胞苷(HD-Ara-C)联合常规化疗治疗的疗效。
The Influence of Cytarabine on the Immunological Function in BALB/ C Mice 阿糖胞苷对BALB/C小鼠免疫功能的影响
This study was designed to assess the utility of high-dose mitoxantrone and intermediate-dose cytarabine in the treatment of patients with relapsed or refractory acute leukemia. 本研究观察了大剂量米托蒽醌和中剂量阿糖胞苷治疗30例难治性或复发的白血病的效果。
Study on the clinical pharmacokinetics of high-dose cytarabine and Its side-effects observation 大剂量阿糖胞苷的临床药代动力学研究及毒副反应观察
Nursing about alternative treatment of acute promyelocyte leukemia by arsenic trioxide and cytarabine 三氧化二砷和阿糖胞苷交替治疗急性早幼粒细胞性白血病的护理
Objective We report our outcome of the intensive intermediate/ high-dose cytarabine ( I/ HIDAC) based chemotherapy followed by autologous stem cell transplantation ( ASCT) for adult acute leukemia patients in the first remission ( CR1). 目的观察第1次完全缓解(CR1)期成年人急性白血病(AL)患者中/大剂量阿糖胞苷(I/HIDAC)序贯强烈化疗后自体造血干细胞移植(ASCT)的安全性及移植疗效。
Moderate dose of cytarabine can penetrate the blood-brain barrier. 中剂量阿糖胞苷可以透过血脑屏障。
However, the activity of cytarabine is decreased by its rapid deamination to the biologically inactive metabolite uracil arabinoside. 然而,阿糖胞苷的半衰期较短,在血及组织中很容易被胞嘧啶脱氨酶迅速脱氨而形成无活性的尿嘧啶阿拉伯糖苷。